Patents by Inventor Yoder T. Wendy

Yoder T. Wendy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Non-toxic non-toxigenic non-pathogenic fusarium expression system
    Patent number: 7163804
    Abstract: The present invention relates non-toxic, non-toxigenic, non-pathogenic recombinant Fusarium host cells of the section Discolor or a teleomorph or synonym thereof, comprising a nucleic acid sequence encoding a heterologous protein operably linked to a promoter.
    Type: Grant
    Filed: December 15, 1999
    Date of Patent: January 16, 2007
    Assignee: Novozymes, Inc.
    Inventors: John C. Royer, Donna L. Moyer, Jeffrey R. Shuster, Yoder T. Wendy
  • Non-toxic, non-toxigenic, non-pathogenic Fusarium expression system
    Patent number: 6060305
    Abstract: The present invention relates non-toxic, non-toxigenic, non-pathogenic recombinant Fusarium host cells of the section Discolor or a teleomorph or synonym thereof, comprising a nucleic acid sequence encoding a heterologous protein operably linked to a promoter.
    Type: Grant
    Filed: March 13, 1997
    Date of Patent: May 9, 2000
    Assignee: Novo Nordisk Biotech, Inc.
    Inventors: John C. Royer, Donna L. Moyer, Yoder T. Wendy, Jeffrey R. Shuster
  • Non-toxic, non-toxigenic, non-pathogenic fusarium expression system and promoters and terminators for use therein
    Patent number: 5837847
    Abstract: The invention is related to a non-toxic, non-toxigenic, non-pathogenic recombinant Fusarium, e.g., Fusarium graminearum host cell comprising a nucleic acid sequence encoding a heterologous protein operably linked to a promoter. The invention further relates to a method for the production of recombinant proteins using such Fusarium host cells. The invention also relates to a promoter and terminator sequence which may be used in such cells.
    Type: Grant
    Filed: August 29, 1997
    Date of Patent: November 17, 1998
    Assignee: Novo Nordisk Biotech, Inc.
    Inventors: John C. Royer, Donna L. Moyer, Yoder T. Wendy, Jeffrey R. Shuster